Previous 10 | Next 10 |
Novavax COVID-19 Vaccine Doses Available at Major Retail Pharmacies Across the U.S. PR Newswire Novavax's updated COVID-19 vaccine is now available at a wide range of retailers, including Costco, CVS Pharmacy, Giant, Publix, Rite Aid, Stop & Shop and Topco Novava...
2023-10-12 14:04:24 ET More on BioNTech, Moderna, etc. Novavax's COVID-19 Investment Thesis Is Old News Investing In Moderna: A Speculative Buy For Long-Term Gains BioNTech: This Beaten Pandemic Star Will Capitalize On Oncology Treatments Pfizer wins FDA nod ...
2023-10-12 06:00:00 ET Novavax (NASDAQ: NVAX) fell behind in the original coronavirus vaccine race as rivals Pfizer and Moderna brought their products to market. The biotech launched its vaccine a year-and-a-half later in the U.S. and therefore missed out on the biggest reve...
Novavax Advances Science Supporting Protein-based Vaccine Technology at IDWeek 2023 and World Vaccine Congress Europe 2023 PR Newswire GAITHERSBURG, Md. , Oct. 11, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccine...
Novavax Launches Choose to Protect™ Campaign to Educate Public About Importance of Updated COVID Vaccination this Fall PR Newswire Partnership with HealthyWomen and actor, mother and business owner Nicole Ari Parker encourages people to get informed about the import...
2023-10-09 16:00:00 ET Summary NVAX's H2'23 estimates appear to be overly bullish, based on PFE's pessimistic commentary with only 24% of the US population likely to be vaccinated with COVID vaccines in 2023. As a result of the potentially reduced demand, we may see NVAX's FY2023 ...
2023-10-08 22:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-10-07 05:30:00 ET Early on in the pandemic, Moderna and Pfizer beat smaller rival Novavax (NASDAQ: NVAX) to market with their coronavirus vaccines by a year or more in some countries. This head start offered them the lion's share of the market and revenue, and Novavax c...
2023-10-06 15:00:00 ET More on the stock market The U.S. Government Shutdown: Not A Crisis SPY Madness: 'Magnificent Seven' Stocks Up An Average 95% YTD While The Average Stock Is Down More Shades Of 2007 Buy-rated dividend stocks for volatility and high rate...
2023-10-06 06:00:00 ET The initial early pandemic vaccine race came to a close long ago, but there's a new race going on -- and one that could be worth billions of dollars in recurring revenue. I'm talking about the race to develop a single product that could protect the population from flu...
News, Short Squeeze, Breakout and More Instantly...
Novavax Submits Application to Health Canada for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine Canada NewsWire Novavax's COVID-19 vaccine would be the only protein-based option available in Canada , if authorized Novavax's filing is aligned with NACI, ...